About 600 reports

Abstract: - Global Biopharmaceuticals Market to Reach $535 Billion by 2027 - Amid the COVID-19 crisis, the global market for Biopharmaceuticals estimated at US$234.5 Billion in the year 2020, is projected to reach a revised size of US$535 Billion by 2027, growing at a CAGR of 12.5% over the analysis period 2020-2027....

  • Biopharmaceutical
  • World
  • China
  • United States

Abstract: - Global Biopharmaceutical Fermentation Systems Market to Reach $14.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Biopharmaceutical Fermentation Systems estimated at US$10.9 Billion in the year 2020, is projected to reach a revised size of US$14.8 Billion by 2027, growing at aCAGR of...

  • Biotechnology
  • Medical Biotechnology
  • Biopharmaceutical
  • World
  • China
  • United States

Abstract: - Global Biopharmaceutical Bioseparation Systems Market to Reach $12.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Biopharmaceutical Bioseparation Systems estimated at US$7.1 Billion in the year 2020, is projected to reach a revised size of US$12.6 Billion by 2027, growing at aCAGR...

  • Industrial Biotechnology
  • Biopharmaceutical
  • World
  • Europe
  • China
  • United States

INCREASING ACCEPTANCE FOR BIOPHARMACEUTICALS

  • Biopharmaceutical
  • Monoclonal Antibody
  • Infectious Disease
  • Vaccine
  • Protein Therapy
  • Biotech Vaccine
  • APAC
  • Indiana
  • Health Expenditure
  • Drug Approval

The global pharmaceuticals, biopharmaceuticals, and neutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments.Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug...

  • Pharmaceutical
  • Biopharmaceutical
  • World
  • China
  • United States
  • APAC
  • Biologics Penetration Rate

Abstract: - Global Biopharmaceuticals Manufacturing Consumables Testing Market to Reach $797.1 Million by 2027 - Amid the COVID-19 crisis, the global market for Biopharmaceuticals Manufacturing Consumables Testing estimated at US$390.7 Million in the year 2020, is projected to reach a revised size of US$797.1 Million...

  • Biopharmaceutical
  • World
  • China
  • United States

## PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

  • Pharmaceutical
  • Biopharmaceutical
  • United States
  • Europe
  • APAC
  • North America
  • Pharmaceutical Production
  • Chronic Disease Prevalence

## BIOPHARMACEUTICAL PRODUCTION

  • Cell Therapy
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Biologics Production
  • Drug Approval

## BIOPHARMACEUTICAL PRODUCTION

  • Biopharmaceutical
  • United States
  • World
  • North America
  • Europe
  • APAC
  • Biologics Sales
  • Biologics Production

Abstract: - Global Healthcare Cold Chain Logistics Market to Reach $18.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Healthcare Cold Chain Logistics estimated at US$11.3 Billion in the year 2020, is projected to reach a revised size of US$18.5 Billion by 2027, growing at a CAGR of 7.3% over the...

  • Logistics
  • Cold Chain
  • Biopharmaceutical
  • Healthcare
  • World
  • China
  • United States

## BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES

  • Healthcare
  • Cell Therapy
  • Biopharmaceutical
  • In Vitro Diagnostics
  • Cancer
  • World
  • United States
  • North America
  • APAC
  • Cancer Incidence
  • Health Expenditure

## PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

  • Drug Development
  • Pharmaceutical
  • Biopharmaceutical
  • Clinical Trial
  • United States
  • APAC
  • Drug Approval
  • Chronic Disease Prevalence

World United Kingdom Biopharmaceutical

  • Pharmaceutical
  • Drug Development
  • Biopharmaceutical
  • Healthcare
  • Infectious Disease
  • World
  • United States
  • Europe
  • APAC
  • Africa
  • Health Expenditure
  • Cancer Incidence

U.S. Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation), By End-use, And Segment Forecasts, 2020 - 2027 U.S. Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends The...

  • Pharmaceutical
  • Biopharmaceutical
  • United States

## BIOPHARMACEUTICAL COMPANIES

  • Pharmaceutical
  • Injectable Delivery
  • Biopharmaceutical
  • Fluoropolymers
  • United States
  • APAC
  • North America
  • Europe
  • Pharmaceutical Production
  • Employment Costs

Major players in the filgrastim biosimilars market are Cadila Pharmaceuticals, Dr. Reddy’s Laboratories, Intas Biopharmaceuticals, Sandoz, Amgen Inc., Dr. Reddy’s Laboratories Ltd, Intas Pharmaceuticals, Emcure Pharmaceuticals Ltd., Biocon and Aryogen Biopharma. The global filgrastim biosimilars market is expected to decline from $511.15...

  • Biosimilar
  • World
  • United States
  • Biosimilar Approvals
  • Biosimilar Penetration Rate

Major players in the biosimilar monoclonal antibodies market are Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics, and Intas Pharmaceuticals Limited. The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion...

  • Biopharmaceutical
  • Monoclonal Antibody
  • United States
  • World
  • Biosimilar Approvals
  • Chronic Disease Prevalence

North America Life Science Tools Market Size, Share & Trends Analysis Report By End-use, By Technology (Cell Biology, Proteomics Technologies), By Product (PCR & qPCR, Cell Biology), And Segment Forecasts, 2020 - 2027 North America Life Science Tools Market Growth & Trends The North America...

  • Life Sciences Tools
  • Molecular Biology
  • Biopharmaceutical
  • United States

## PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

  • Drug Development
  • Cell Therapy
  • United States
  • World
  • North America
  • APAC
  • Europe
  • Pharmaceutical R&D Expenditure
  • Gross Domestic Expenditure On R&D

“Adalimumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 35+ marketed and pipeline drugs in Adalimumab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage,...

  • Monoclonal Antibody
  • Autoimmune Disease
  • China
  • United States
  • Biosimilar Approvals

## BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS

  • Cell Therapy
  • United States
  • Europe
  • APAC
  • Cancer Incidence
  • Health Expenditure

‘Crohn’s Disease (CD) - Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the CD, historical and forecasted epidemiology as well as the CD market trends in the United States. The CD market report provides current treatment practices, emerging drugs, CD market share of the individual therapies,...

  • Therapy
  • Monoclonal Antibody
  • United States
  • Health Expenditure
  • Drug Approval

## PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

  • Healthcare
  • Regenerative Medicine
  • Biotechnology
  • Dementia
  • United States
  • World
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Chronic Disease Prevalence

Sino Biopharmaceutical Ltd

  • Biopharmaceutical
  • Pharmaceutical
  • Oncology
  • World
  • Zhejiang
  • Indiana
  • Pharmaceutical Registrations
  • Stem Cell Transplantation

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. United States Single Use Assemblies Market By Product (Bag Assembly, Filtration Assembly, Bottle Assembly, Mixing Assembly, Others), By Solution...

  • Pharmaceutical
  • Biopharmaceutical
  • Drug Development
  • Cell Therapy
  • United States

Major players in the TNF alpha inhibitors market are AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., UCB S.A, Novartis International AG, Pfizer, Inc., Merck & co., Inc., Janssen Biotech, Ablynx, and Momenta Pharmaceuticals. The global TNF alpha inhibitors market is expected to decline from $40.66 billion in 2019 to $39.01...

  • Autoimmune Disease
  • Monoclonal Antibody
  • World
  • United States
  • APAC

Biopharmaceutical Cell Therapy Pharmaceutical Life Sciences Regenerative Medicine Biotechnology

  • Pharmaceutical
  • Cell Therapy
  • Biotechnology
  • Research And Development
  • United States
  • World
  • North America
  • Europe
  • APAC
  • Biologics Production
  • Health Expenditure

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. United States Chromatography Resin Market By Type (Natural, Synthetic, Inorganic Media), By Technique (Ion Exchange, Affinity, Hydrophobic Interaction,...

  • Pharmaceutical
  • Resins
  • Biotechnology
  • Advertising
  • Synthetic Resin
  • Immunotherapy
  • Marketing Research
  • Laboratory Equipment
  • Biopharmaceutical
  • In-Store Retail
  • Beverage
  • United States

GenScript and SunRock Biopharma

  • Drug Development
  • Monoclonal Antibody
  • Biotechnology
  • Polyclonal Antibody
  • Infectious Disease
  • United States
  • APAC
  • Cancer Incidence
  • Direct Sales

Major players in the vascular endothelial growth factor (VEGF) inhibitor market are Pfizer, Amgen, Roche, Xbrane Biopharma AB, Genentech Inc., AstraZeneca plc, Bayer AG, Eli Lilly and Company and Allergan plc. The global vascular endothelial growth factor (VEGF) inhibitor market is expected to decline from $0.31 billion in 2019 to $0.28...

  • Pharmaceutical
  • Ophthalmology
  • Targeted Therapy
  • Eye Disease
  • Biopharmaceutical
  • Wound Care
  • Biotechnology
  • World
  • United States
  • Cancer Incidence